Niki Arrowsmith04.11.13
Center Valley, Pa.-based Olympus Medical Systems Group has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Olympus articulating HD (high-definition) 3-D laparoscopic surgical video system.
The system is touted to reduce surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2-D surgical systems, based on internal Olympus testing conducted using a simulated surgical model. This is accomplished by restoring natural 3-D vision and depth perception when performing laparoscopic procedures and is independent of a surgeon’s skill level.
“The Olympus HD 3-D system is ideal for suturing, accurately identifying tissue planes and other precision surgical tasks that are required in my laparoscopic surgical cases,” said Marcos Michellotti, M.D., assistant professor of surgery at Loma Linda University Health System in Loma Linda, Calif. “In addition, the articulating design enables me to obtain the critical view of anatomical structures in HD 3-D without losing the important visual horizon. This is not possible with traditional fixed angle laparoscopes.”
The Olympus HD 3-D video platform is available as a module that can be added to the existing Olympus Evis Exera III universal imaging system. The modular design reportedly reduces the investment necessary to add 3-D capability, and allows the surgeon to choose either 2-D or 3-D visualization from the surgical field. This helps to reduce capital investments and simplify asset management and training.
“The Olympus HD 3-D system brings value to those surgeons that need the precision, resolution, and depth perception of 3-D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology,” said Luke Calcraft, president of the Medical Systems Group at Olympus Corporation of the Americas. “We are leading the way with new innovations to help our customers realize the clinical efficacy and cost effectiveness required under accountable care.”
Olympus Medical Systems Group, a division of technology company Olympus, makes devices for less invasive procedures, diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments.
The system is touted to reduce surgical errors and improving the speed, accuracy and precision of surgical tasks such as dissection, grasping and suturing when compared with traditional 2-D surgical systems, based on internal Olympus testing conducted using a simulated surgical model. This is accomplished by restoring natural 3-D vision and depth perception when performing laparoscopic procedures and is independent of a surgeon’s skill level.
“The Olympus HD 3-D system is ideal for suturing, accurately identifying tissue planes and other precision surgical tasks that are required in my laparoscopic surgical cases,” said Marcos Michellotti, M.D., assistant professor of surgery at Loma Linda University Health System in Loma Linda, Calif. “In addition, the articulating design enables me to obtain the critical view of anatomical structures in HD 3-D without losing the important visual horizon. This is not possible with traditional fixed angle laparoscopes.”
The Olympus HD 3-D video platform is available as a module that can be added to the existing Olympus Evis Exera III universal imaging system. The modular design reportedly reduces the investment necessary to add 3-D capability, and allows the surgeon to choose either 2-D or 3-D visualization from the surgical field. This helps to reduce capital investments and simplify asset management and training.
“The Olympus HD 3-D system brings value to those surgeons that need the precision, resolution, and depth perception of 3-D without the substantial capital investment and annual maintenance expenses associated with alternatives such as robotic technology,” said Luke Calcraft, president of the Medical Systems Group at Olympus Corporation of the Americas. “We are leading the way with new innovations to help our customers realize the clinical efficacy and cost effectiveness required under accountable care.”
Olympus Medical Systems Group, a division of technology company Olympus, makes devices for less invasive procedures, diagnostic and therapeutic endoscopy, and early stage lung cancer evaluation and treatments.